Manufacturing Chemist Manufacturing Chemist
  • Home
  • Ingredients
  • Analysis
  • Manufacturing
  • Finance
  • Events
  • Directory
  • Regulatory
  • Drug Delivery
  • Research & Development
  • Sustainability

Daiichi Sankyo

www.daiichisankyo.com

3-5-1 Nihonbashi Honcho
Chuo-ku
Tokyo
103-8426
Japan

+81 3 6225 1126

Activities

Packaging | Research & Development | Pharmaceutical

Related Companies

  • Romaco Holding GmbH
  • Nipro PharmaPackaging International
  • ProtaGene
  • Starlab
  • Lonza
  • Schott Pharma AG and Co. KGaA
  • Piramal Pharma Solutions
  • PCI Pharma Services
  • Biotech Fluidics AB
  • Nanoform
  • Indena
  • Quotient Sciences
  • Actylis – The Partner of Choice
  • SGS Health Sciences
  • Marchesini Group
  • Hermes Pharma GmbH
  • Vectorbuilder Inc
  • Butterworth Laboratories
  • Intelsius
  • DWK Life Sciences

Related Content

AstraZeneca and Daiichi Sankyo reveal phase 3 lung cancer study
AstraZeneca and Daiichi Sankyo reveal phase 3 lung cancer study
ProLynx collaborates with Daiichi Sankyo on drug delivery
ProLynx collaborates with Daiichi Sankyo on drug delivery
Heptares Therapeutics enters agreement with Daichi Sankyo
Heptares Therapeutics enters agreement with Daichi Sankyo
Amgen and Daiichi Sankyo to commercialise biosimilars in Japan
Amgen and Daiichi Sankyo to commercialise biosimilars in Japan
Nitto Denko enters drug delivery partnership with Daiichi Sankyo
Nitto Denko enters drug delivery partnership with Daiichi Sankyo
Daiichi Sankyo appoints Antoine Yver as Global Head, Oncology Research and Development
Daiichi Sankyo appoints Antoine Yver as Global Head, Oncology Research and Development
Latest EU drug approvals span range of health issues
Latest EU drug approvals span range of health issues
Daiichi Sankyo closes its research unit in Germany
Daiichi Sankyo closes its research unit in Germany
Daiichi Sankyo to cut up to 1,200 jobs in the US
Daiichi Sankyo to cut up to 1,200 jobs in the US
Daiichi Sankyo to acquire US biotechnology company Ambit Biosciences
Daiichi Sankyo to acquire US biotechnology company Ambit Biosciences
Reimbursment issues hinder future development of personal therapies
Reimbursment issues hinder future development of personal therapies
Japan funds R&D for tropical medicines for poor countries
Japan funds R&D for tropical medicines for poor countries
Daiichi Sankyo, Virtici and Celdara Medical enter high potential therapeutics collaboration
Daiichi Sankyo, Virtici and Celdara Medical enter high potential therapeutics collaboration
Opioid-induced constipation – naloxegol
Opioid-induced constipation – naloxegol
Daiichi Sankyo makes two executive appointments
Daiichi Sankyo makes two executive appointments
  • Advertise Subscribe
  • Terms & Conditions
  • Privacy Policy
  • Contact us at info@hpcimedia.com
Twitter LinkedIn RSS newsfeed
© HPCi Media Limited | Registered in England No. 06716035 | VAT GB 939828072 | a Claverley Group company